Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Jackson

Showing results (201-210 of 251) with videos related to

Pageof 26
Sort By:
The Biochemical Journal|August 12, 2005
Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexitySylvain Pitarque, Jean-Louis Herrmann, Jean-Luc Duteyrat, et al.
Circulation. Genomic and Precision Medicine|October 23, 2019
Broad Genetic Testing in a Clinical Setting Uncovers a High Prevalence of Titin Loss-of-Function Variants in Very Early Onset Atrial FibrillationWilliam R Goodyer, Kyla Dunn, Colleen Caleshu, et al.
Bioorganic & Medicinal Chemistry|August 16, 2011
The structure-activity relationship of urea derivatives as anti-tuberculosis agentsJoshua R Brown, Elton J North, Julian G Hurdle, et al.
The Journal of Biological Chemistry|May 29, 2012
Mechanistic insights into the retaining glucosyl-3-phosphoglycerate synthase from mycobacteriaSaioa Urresti, David Albesa-Jové, Francis Schaeffer, et al.
The Journal of Biological Chemistry|October 6, 2012
A small multidrug resistance-like transporter involved in the arabinosylation of arabinogalactan and lipoarabinomannan in mycobacteriaGérald Larrouy-Maumus, Henrieta Škovierová, Rabeb Dhouib, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Proton transfer activity of the reconstituted <i>Mycobacterium tuberculosis</i> MmpL3 is modulated by substrate mimics and inhibitorsCasey M Stevens, Svitlana O Babii, Amitkumar N Pandya, et al.
International Journal of Molecular Sciences|March 25, 2022
2-Aminoimidazoles Inhibit <i>Mycobacterium abscessus</i> Biofilms in a Zinc-Dependent MannerJuan M Belardinelli, Wei Li, Kevin H Martin, et al.
Plos One|July 28, 2017
2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeabilityAlbert B Jeon, Andrés Obregón-Henao, David F Ackart, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2024
Lipoarabinomannan modification as a source of phenotypic heterogeneity in host-adapted <i>Mycobacterium abscessus</i> isolatesKavita De, Juan M Belardinelli, Arun Prasad Pandurangan, et al.
Memorias Do Instituto Oswaldo Cruz|January 4, 2013
Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosyJohn S Spencer, Malcolm S Duthie, Annemieke Geluk, et al.
Pageof 26

Showing results (201-210 of 251) with videos related to

Sort By:
Pageof 26
The Biochemical Journal|August 12, 2005
Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexitySylvain Pitarque, Jean-Louis Herrmann, Jean-Luc Duteyrat, et al.
Circulation. Genomic and Precision Medicine|October 23, 2019
Broad Genetic Testing in a Clinical Setting Uncovers a High Prevalence of Titin Loss-of-Function Variants in Very Early Onset Atrial FibrillationWilliam R Goodyer, Kyla Dunn, Colleen Caleshu, et al.
Bioorganic & Medicinal Chemistry|August 16, 2011
The structure-activity relationship of urea derivatives as anti-tuberculosis agentsJoshua R Brown, Elton J North, Julian G Hurdle, et al.
The Journal of Biological Chemistry|May 29, 2012
Mechanistic insights into the retaining glucosyl-3-phosphoglycerate synthase from mycobacteriaSaioa Urresti, David Albesa-Jové, Francis Schaeffer, et al.
The Journal of Biological Chemistry|October 6, 2012
A small multidrug resistance-like transporter involved in the arabinosylation of arabinogalactan and lipoarabinomannan in mycobacteriaGérald Larrouy-Maumus, Henrieta Škovierová, Rabeb Dhouib, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Proton transfer activity of the reconstituted <i>Mycobacterium tuberculosis</i> MmpL3 is modulated by substrate mimics and inhibitorsCasey M Stevens, Svitlana O Babii, Amitkumar N Pandya, et al.
International Journal of Molecular Sciences|March 25, 2022
2-Aminoimidazoles Inhibit <i>Mycobacterium abscessus</i> Biofilms in a Zinc-Dependent MannerJuan M Belardinelli, Wei Li, Kevin H Martin, et al.
Plos One|July 28, 2017
2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeabilityAlbert B Jeon, Andrés Obregón-Henao, David F Ackart, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2024
Lipoarabinomannan modification as a source of phenotypic heterogeneity in host-adapted <i>Mycobacterium abscessus</i> isolatesKavita De, Juan M Belardinelli, Arun Prasad Pandurangan, et al.
Memorias Do Instituto Oswaldo Cruz|January 4, 2013
Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosyJohn S Spencer, Malcolm S Duthie, Annemieke Geluk, et al.
Pageof 26